News
Investor's Business Daily on MSN1d
Novo Nordisk Just Leapfrogged Eli Lilly With A Weight-Loss Pill; Shares PopNovo Nordisk stock popped Tuesday on reports it's asked the FDA to approve its weight-loss pill, an oral version of Wegovy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback